Saudi Arabia Pharmacovigilance Market Size & Outlook

Name: Saudi Arabia Pharmacovigilance Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The pharmacovigilance market in Saudi Arabia is expected to reach a projected revenue of US$ 56.6 million by 2033. A compound annual growth rate of 5.9% is expected of Saudi Arabia pharmacovigilance market from 2026 to 2033.

Saudi Arabia pharmacovigilance product life cycle outlook (Revenue, USD million, 2021-2033)
- Pre Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
Saudi Arabia pharmacovigilance service provider outlook (Revenue, USD million, 2021-2033)
- In House
- Contract outsourcing
Saudi Arabia pharmacovigilance type outlook (Revenue, USD million, 2021-2033)
- Spontaneous reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
Saudi Arabia pharmacovigilance end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
Saudi Arabia pharmacovigilance therapeutic area outlook (Revenue, USD million, 2021-2033)
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
Saudi Arabia pharmacovigilance process flow outlook (Revenue, USD million, 2021-2033)
- Case Data Management
  - Case Logging
  - Case Data Analysis
  - Medical Reviewing & Reporting
- Signal Detection
  - Adverse Event Logging
  - Adverse Event Analysis
  - Adverse Event Review & Reporting
- Risk Management System
  - Risk Evaluation System
  - Risk Mitigation System

Saudi Arabia Pharmacovigilance Market Size & Outlook

Sign up - it's easy, and free!